Literature DB >> 16923802

Quantitative analysis of anti-apoptotic function of Akt in Akt1 and Akt2 double knock-out mouse embryonic fibroblast cells under normal and stressed conditions.

Xuesong Liu1, Yan Shi, Morris J Birnbaum, Keqiang Ye, Ron De Jong, Tillman Oltersdorf, Vincent L Giranda, Yan Luo.   

Abstract

The serine/threonine kinases Akt1/PKBalpha, Akt2/PKBbeta, and Akt3/PKBgamma have been implicated in preventing cells from undergoing apoptosis. Although several small molecule inhibitors of Akt have been reported to induce apoptosis in cancer cells, these inhibitors may have additional targets. In the current study, we used an Akt3 small interfering RNA (Akt3 siRNA) to analyze apoptosis induction in Akt1 and Akt2 double knock-out mouse embryonic fibroblast cells (MEF-Akt1,2-DKO). Our data indicated that Akt3 siRNA inhibited Akt3 protein expression in a dose-dependent manner. As a result, phosphorylation of Akt and its downstream targets, including FKHRL1 and GSK3alpha/beta, were reduced accordingly. The treatment also induced apoptosis in MEF-Akt1,2-DKO cells. However, apoptosis induction is significant only when more than 80% of Akt3 protein was depleted. Reintroducing Akt3 totally rescued Akt3-siRNA-induced apoptosis in MEF-Akt1,2-DKO cells. In addition, reintroducing Akt1 also inhibited apoptosis induced by Akt3 siRNA. Moreover, Akt3 siRNA potentiated different stress-induced apoptosis in MEF-Akt1,2-DKO cells at a lower dose when compared with what is required for apoptosis induction by itself. Our study suggests that only a small portion of Akt is active in wild-type MEF cells and a threshold of Akt inhibition is required to induce apoptosis by pure Akt inhibitors. In addition, our data indicate that cells under stress require more Akt for its survival.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16923802     DOI: 10.1074/jbc.M606603200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  19 in total

1.  Differential regulation of CIDEA and CIDEC expression by insulin via Akt1/2- and JNK2-dependent pathways in human adipocytes.

Authors:  Minoru Ito; Michiaki Nagasawa; Naoki Omae; Tomohiro Ide; Yunike Akasaka; Koji Murakami
Journal:  J Lipid Res       Date:  2011-06-02       Impact factor: 5.922

2.  AKT1 and AKT2 maintain hematopoietic stem cell function by regulating reactive oxygen species.

Authors:  Marisa M Juntilla; Vineet D Patil; Marco Calamito; Rohan P Joshi; Morris J Birnbaum; Gary A Koretzky
Journal:  Blood       Date:  2010-03-30       Impact factor: 22.113

3.  Loss of 2 Akt (Protein Kinase B) Isoforms in Hematopoietic Cells Diminished Monocyte and Macrophage Survival and Reduces Atherosclerosis in Ldl Receptor-Null Mice.

Authors:  Vladimir R Babaev; Lei Ding; Youmin Zhang; James M May; Stephen A Ramsey; Kasey C Vickers; MacRae F Linton
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-02       Impact factor: 8.311

4.  The role of mouse Akt2 in insulin-dependent suppression of adipocyte lipolysis in vivo.

Authors:  Shlomit Koren; Lisa M DiPilato; Matthew J Emmett; Abigail L Shearin; Qingwei Chu; Bob Monks; Morris J Birnbaum
Journal:  Diabetologia       Date:  2015-03-05       Impact factor: 10.122

5.  Platelet-derived growth factor-BB activates calcium/calmodulin-dependent and -independent mechanisms that mediate Akt phosphorylation in the neurofibromin-deficient human Schwann cell line ST88-14.

Authors:  Robert G Farrer; Jason R Farrer; George H DeVries
Journal:  J Biol Chem       Date:  2013-03-01       Impact factor: 5.157

6.  Akt inhibitor a-443654 interferes with mitotic progression by regulating aurora a kinase expression.

Authors:  Xuesong Liu; Yan Shi; Keith W Woods; Paul Hessler; Paul Kroeger; Julie Wilsbacher; Jieyi Wang; Jean Y Wang; Chunying Li; Qun Li; Saul H Rosenberg; Vincent L Giranda; Yan Luo
Journal:  Neoplasia       Date:  2008-08       Impact factor: 5.715

7.  Role of Akt isoforms in IGF-I-mediated signaling and survival in myoblasts.

Authors:  Ronald W Matheny; Martin L Adamo
Journal:  Biochem Biophys Res Commun       Date:  2009-08-22       Impact factor: 3.575

8.  Inhibition of the phosphatidylinositol 3-kinase-Akt pathway enhances gamma-2 herpesvirus lytic replication and facilitates reactivation from latency.

Authors:  Li Peng; Ting-Ting Wu; Jason H Tchieu; Jun Feng; Helen J Brown; Jiaying Feng; Xudong Li; Jing Qi; Hongyu Deng; Igor Vivanco; Ingo K Mellinghoff; Christina Jamieson; Ren Sun
Journal:  J Gen Virol       Date:  2009-10-28       Impact factor: 3.891

9.  Functional interdependence at the chromatin level between the MKK6/p38 and IGF1/PI3K/AKT pathways during muscle differentiation.

Authors:  Carlo Serra; Daniela Palacios; Chiara Mozzetta; Sonia V Forcales; Ianessa Morantte; Meri Ripani; David R Jones; Keyong Du; Ulupi S Jhala; Cristiano Simone; Pier Lorenzo Puri
Journal:  Mol Cell       Date:  2007-10-26       Impact factor: 17.970

10.  Effects of PI3K catalytic subunit and Akt isoform deficiency on mTOR and p70S6K activation in myoblasts.

Authors:  Ronald W Matheny; Martin L Adamo
Journal:  Biochem Biophys Res Commun       Date:  2009-09-30       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.